triazoles has been researched along with Chronic Disease in 132 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 3 (2.27) | 18.7374 |
| 1990's | 12 (9.09) | 18.2507 |
| 2000's | 66 (50.00) | 29.6817 |
| 2010's | 48 (36.36) | 24.3611 |
| 2020's | 3 (2.27) | 2.80 |
| Authors | Studies |
|---|---|
| Bao, SJ; Cai, XH; Chen, JY; Fang, L; Gyabaah, AT; Hong, FF; Hu, SY; Li, XC; Li, YA; Li, ZL; Ma, CY; Shao, GH; Tu, YJ; Ying, HY; Yu, CY; Zhang, ZL | 1 |
| Bossu, A; van Weperen, VYH; Vos, MA | 1 |
| Bailly, É; Bernard, L; Carvalho-Schneider, C; Cottier, JP; Desoubeaux, G; Destrieux, C; Garot, D; Hobson, CA; Le Brun, C; Lemaignen, A; Maakaroun, Z | 1 |
| Borghi, C; Cicero, AFG; Fogacci, F; Kuwabara, M | 1 |
| Kuehn, BM | 1 |
| Nakao, M; Nishimura, S | 1 |
| Denning, DW; Harris, C; Kosmidis, C; Muldoon, EG; Newton, PJ; Rodriguez-Goncer, I | 1 |
| Robinson, PC | 1 |
| Coombs, GW; Dyer, JR; Gardam, DJ; Heath, CH; Pang, S | 1 |
| Bongomin, F; Felton, T; Maguire, N; Moore, CB; Rautemaa-Richardson, R | 1 |
| Denning, DW; Kosmidis, C; Moore, CB; Rautemaa-Richardson, R; Richardson, MD; Rodriguez-Goncer, I | 1 |
| Bravo, F; Bustamante, B; Salomon, M; Seas, C | 1 |
| Kontoghiorghes, GJ | 1 |
| Arnow, BA; Blasey, C; Klein, DN; Kocsis, JH; Manber, R; Markowitz, JC; Rothbaum, BO; Steidtmann, D; Thase, ME | 1 |
| McNeil, C | 1 |
| Dasararaju, R; Many, WJ; Samant, JS | 1 |
| Badoual, C; Devars Du Mayne, M; El Naderi, S; Rodriguez, C | 1 |
| Halderman, A; Shrestha, R; Sindwani, R | 1 |
| Blanco-Grau, A; Cabezos, J; Gómez i Prat, J; Molina, I; Pahissa, A; Pou, D; Roure, S; Salvador, F; Sánchez-Montalvá, A; Serre, N; Sulleiro, E; Treviño, B; Valerio, L; Vidal, X | 1 |
| Han, M; Huang, H; Huang, X; Ji, Y; Meng, F; Ren, H; Shen, Z; Sun, Y; Wang, C; Wu, D; Yu, L; Zhang, X | 1 |
| Chatelain, E; Francisco, AF; Jayawardhana, S; Kelly, JM; Lewis, MD; Taylor, MC | 2 |
| Basta-Kaim, A; Jurga, A; Kwiatkowski, K; Makuch, W; Mika, J; Piotrowska, A; Rojewska, E; Slusarczyk, J; Trojan, E | 1 |
| McKerrow, JH; Urbina, JA | 1 |
| Carbonari, DM; Corley, DA; Forde, KA; Goldberg, DS; Haynes, K; Lewis, JD; Lo Re, V; Marks, AR; Reddy, KR; Roy, JA; Schneider, JL; Sha, D; Strom, BL | 1 |
| Huang, P; Huang, S; Liu, X; Luo, X; Qi, J; Shen, X; Wang, J; Yang, Z; Zhong, Y | 1 |
| Jacobsen, AA; Papo, YB; Sarro, R; Strasswimmer, J; Weisse, K | 1 |
| Ang, D; De Santis, A; Pauwels, A; Scarpellini, E; Tack, J; Vanuytsel, T | 1 |
| Al-Shair, K; Denning, DW; Harris, C; Lowes, D; Morris, J; Newton, PJ; Rautemaa-Richardson, R | 1 |
| Apt, W; Beloscar, J; Bonilla, LR; Colombo, H; Cuneo, C; Del Carmen Bangher, M; Echeverria, LE; Gao, P; Gascon, J; Mallagray, M; McCarthy, M; Meeks, B; Milesi, R; Molina, I; Morillo, CA; Perez-Molina, JA; Sosa-Estani, S; Waskin, H; Wei, B; Wyss, F; Yusuf, S | 1 |
| Arnow, BA; Gelenberg, AJ; Keller, ME; Klein, DN; Kocsis, JH; Kraemer, HC; Manber, R; Rothbaum, BO; Rush, AJ; Thase, ME; Trivedi, MH | 1 |
| Cordier, JF; Cottin, V; Cristea, D; Meyronet, D; Persat, F | 1 |
| Hayabuchi, T; Konishi, T; Kurai, J; Shimizu, E | 1 |
| Bagust, A; Boland, A; Chu, P; Dickson, R; Dundar, Y; Fleeman, N; Greenhalgh, J; Kirkham, J; McLeod, C; Modell, B; Olujohungbe, A; Telfer, P; Walley, T | 1 |
| Baba, T; Endo, T; Hagiwara, E; Komatsu, S; Matsumoto, Y; Nishihira, R; Ogura, T; Sato, T; Sekine, A; Shinohara, T; Sogo, Y; Takahashi, H | 1 |
| Arnow, B; Klein, DN; Kocsis, JH; Leon, AC; Manber, R; Markowitz, JC; Thase, ME | 1 |
| Arnow, BA; Blalock, JA; Keitner, GI; Klein, DN; Maddux, RE; Manber, R; Markowitz, JC; Riso, LP; Rothbaum, BO; Thase, ME | 1 |
| Konje, JC; Verma, A | 1 |
| de La Blanchardière, A; de La Gastine, B; Fromager, G; Gendrot, A; Massias, L; Verdon, R | 1 |
| Ackerman, Z; Avraham, Y; Berry, EM; Magen, I; Mechoulam, R; Vorobiev, L | 1 |
| Arnow, BA; Carmody, TJ; Denton, WH; Keller, MB; Klein, DN; Rush, AJ; Thase, ME; Trivedi, MH | 1 |
| Choe, DH; Kang, MS; Kim, CH; Lee, JC; Noh, GY | 1 |
| Cowen, EW; Fox, LP; McCalmont, TH; Miller, DD; Nguyen, JC | 1 |
| Fujita, T; Haba, R; Nishiuchi, T; Ohnishi, H; Okutani, Y; Yoshida, K | 1 |
| Jensen, SG; Nielsen, TL | 1 |
| Bertrand, DM; Eas, F; Godin, M; Grangé, S; Guerrot, D | 1 |
| Crits-Christoph, P; Klein, DN; Manber, R; Stulz, N; Thase, ME | 1 |
| Joslin, CE; Shoff, ME; Tu, EY | 1 |
| Clayton, J | 1 |
| Amitani, R; Izumikawa, K; Kakeya, H; Kohno, S; Kurashima, A; Miyazaki, Y; Niki, Y; Ogawa, K; Okimoto, N | 1 |
| Baxter, C; Denning, DW; Felton, TW; Hope, WW; Moore, CB; Roberts, SA | 1 |
| Spellman, CW | 1 |
| Bowyer, P; Bueid, A; Denning, DW; Fraczek, MG; Gore, R; Kirwan, M; Lass-Florl, C; Moore, CB; Park, S; Perlin, DS; Smith, J | 1 |
| Baxter, CG; Denning, DW; Felton, TW; Marshall, A; Roberts, M | 1 |
| Le Loup, G; Lescure, FX; Pialoux, G | 1 |
| Homans, J; Larsen, RA; Neely, M; Schein, R | 1 |
| Abad, M; Casado, JL; Dahl, V; Díaz, L; Dronda, F; Gutiérrez, C; Hernández-Novoa, B; Madrid, N; Moreno, AM; Moreno, S; Muñoz, E; Muñoz-Fernández, MÁ; Navas, E; Palmer, S; Pérez-Elías, MJ; Rubio, R; Vallejo, A; Zamora, J | 1 |
| Bansal, VK; Singh, SK; Valyi-Nagy, T; Villano, JL; Wiley, EL | 1 |
| Bergeron, A; Bergot, E; Bourdin, A; Cadranel, J; Cottin, V; Germaud, P; Godet, C; Hennequin, C; Jeanfaivre, T; Philippe, B; Pineau, M | 1 |
| Das, S; Gupta, N; Jain, S; Malik, JN | 1 |
| Fujiuchi, S; Kato, T; Kawabata, M; Kuba, M; Kurashima, A; Ogawa, K; Saito, T; Sakatani, M; Sasaki, Y; Suzuki, K; Tada, A; Tao, Y | 1 |
| Albarrag, AM; Anderson, MJ; Bowyer, P; Denning, DW; Gregson, L; Harrison, E; Howard, SJ; Leatherbarrow, H; Pasqualotto, AC | 1 |
| Arnow, BA; Borian, FE; Dunner, DL; Gelenberg, AJ; Hirschfeld, RM; Keller, MB; Kornstein, SG; Manber, R; Ninan, PT; Rush, AJ; Thase, ME; Trivedi, MH; Zajecka, J | 1 |
| Brener, Z; Lira, R; Molina, J; Payares, G; Romanha, AJ; Sanoja, C; Urbina, JA | 1 |
| Beckham, JC; Davidson, JR; Feldman, ME; Hertzberg, MA; Moore, SD | 1 |
| Amow, B; Borian, FE; Dunner, DL; Keller, B; Klein, D; Korenstein, SG; Manber, R; Markowitz, JC; Munsaka, M; Rush, AJ; Thase, ME; Trivedi, MH | 1 |
| Lenoci, M; Leykin, Y; Maglione, ML; Marmar, CR; Metzler, TJ; Neylan, TC; Rosenlicht, NZ; Schoenfeld, FB | 1 |
| Berk, M; Wynchank, D | 1 |
| Arnow, B; Blalock, JA; Blasey, C; Keller, MB; Klein, DN; Manber, R; Markowitz, JC; McCullough, JP; Riso, LP; Rothbaum, B; Rush, AJ; Thase, ME; Vivian, D | 1 |
| Arnow, B; Banks, P; Borian, FE; Dunner, DL; Gelenberg, AJ; Hirschfeld, RM; Howland, R; Keitner, GI; Keller, MB; Klein, DN; Kocsis, JH; Kornstein, SG; Manber, R; Markowitz, JC; Miller, I; Munsaka, M; Rothbaum, B; Rush, AJ; Russell, JM; Thase, ME; Trivedi, MH; Zajecka, J | 1 |
| Dunner, DL; Heim, CM; Keitner, G; Keller, MB; Klein, DN; Kornstein, S; McCullough, JP; Nemeroff, CB; Ninan, PT; Rothbaum, BO; Rush, AJ; Schatzberg, AF; Thase, ME; Weiss, PM | 1 |
| Mehta, J; Trifilio, S; Verma, A; Williams, S; Zembower, T | 1 |
| Arnow, B; Borian, FE; Dunner, DL; Keitner, G; Keller, MB; Klein, DN; Kocsis, JH; Koran, LM; Kornstein, SG; Markowitz, JC; Rush, AJ; Trivedi, MH | 1 |
| Danaher, PJ; Walter, EA | 1 |
| Imoto, K; Kato, M; Miyaji, S; Miyake, H; Nakamura, M; Oda, T | 1 |
| Chiodo, F; Consales, A; Manfredi, R; Pavoni, M; Sabbatani, S | 1 |
| Arnow, B; Borian, FE; Carmody, TJ; Dunner, DL; Fawcett, J; Gelenberg, AJ; Ibrahim, HM; Jody, DN; Keitner, GI; Keller, MB; Klein, DN; Kocsis, JH; Kornstein, SG; Manber, R; Markowitz, JC; Nemeroff, CB; Rush, AJ; Russell, JM; Thase, ME; Trivedi, MH | 1 |
| Arnow, BA; Banks, PL; Blalock, JA; Borian, FE; Howland, R; Keller, MB; Klein, DN; Kocsis, JH; Kornstein, SG; Manber, R; Markowitz, JC; Miller, I; Ninan, PT; Rothbaum, BO; Rush, AJ; Schatzberg, AF; Thase, ME; Trivedi, MH | 1 |
| Denning, DW; Jain, LR | 1 |
| Magalhaes, EP; Nehemy, MB; Torqueti-Costa, L; Vasconcelos-Santos, DV | 1 |
| Denning, DW; Dupont, B; Lode, H; Sambatakou, H | 1 |
| Arnow, BA; Blasey, C; Constantino, MJ; Klein, DN; Kocsis, JH; Manber, R; Markowitz, JC; Rush, AJ; Thase, ME | 1 |
| Proia, LA; Trenholme, GM | 1 |
| Hasegawa, Y; Hitomi, S; Imagawa, S; Ishii, Y; Kaneko, S; Kojima, H; Machino, T; Mukai, HY; Muto, H; Nagasawa, T; Okoshi, Y; Suzukawa, K | 1 |
| Bergeron, A; Cadranel, J; Camuset, J; Dauriat, G; Dombret, MC; Henno, P; Mangiapan, G; Nunes, H; Philippe, B; Rabbat, A | 1 |
| Mylona, S; Ntai, S; Pomoni, M; Thanos, L; Tzavara, V | 1 |
| Bedaiwy, MA; Casper, RF; Mousa, NA | 1 |
| Anstead, GM; Catanzaro, A; Gaona-Flores, V; Graybill, JR; Pedicone, L; Rendon, A; Stevens, DA | 1 |
| Hamanaka, N; Hiroi, N; Homma, S; Isobe, K; Kikuchi, N; Kimura, K; Muraoka, S; Shibuya, K; Shimizu, K; Sugino, K; Takai, Y; Yamazaki, Y | 1 |
| Fujita, M; Harada, E; Ikegame, S; Inoshima, I; Nakanishi, Y; Ouchi, H | 1 |
| Keam, SJ; Keating, GM; Yang, LP | 1 |
| Chandrasekar, P; Krishna, G; Martinho, M; Patino, H; Ullmann, AJ | 1 |
| Ahmadi, S; Brockhaus, J; Brune, K; Fritschy, JM; Hess, A; Hösl, K; Knabl, J; Möhler, H; Reinold, H; Rudolph, U; Sergejeva, M; Witschi, R; Zeilhofer, HU; Zeilhofer, UB | 1 |
| Golinval, O; Louis, R | 1 |
| Anton, SF; Archibald, DG; English, PA; Kensler, TT; Roberts, DL; Robinson, DS | 1 |
| Brummer, E; Coffman, RL; Hostetler, JS; Stevens, DA | 1 |
| Heremans, A; Lucker, GP; Steijlen, PM; van de Kerkhof, PC; van Pelt, H | 1 |
| Connor, KM; Davidson, JR; Malik, ML; Weisler, RH | 1 |
| Barza, L; David, D; Mellman, TA | 1 |
| Brotto, LA; Gorzalka, BB; Hanson, LA | 1 |
| Brener, Z; Loebenberg, D; Martins-Filho, O; Molina, J; Romanha, AJ; Urbina, JA | 1 |
| Davis, LL; Kramer, GL; Murray, J; Nugent, AL; Petty, F | 1 |
| Benzick, JM; Faber, RA | 1 |
| Arnow, B; Dunner, DL; Gelenberg, AJ; Keller, MB; Klein, DN; Markowitz, JC; McCullough, JP; Nemeroff, CB; Russell, JM; Thase, ME; Trivedi, MH; Zajecka, J | 1 |
| Scott, J | 1 |
| Chentsova-Dutton, YE; Ellenor, GL; Gillin, JC; Kline, NA; Kodsi, AB; Smith-Vaniz, A; Zisook, S | 1 |
| Kocsis, JH | 1 |
| Baty, P | 1 |
| Rubin, RT | 1 |
| Umanoff, DF | 1 |
| Duncan, BL; Miller, SD | 1 |
| Veijola, JM | 1 |
| Czaika, V; Schmalreck, A; Schultze, W; Sterry, W; Tietz, HJ | 1 |
| Dunner, DL | 1 |
| Lake, AE; Saper, JR; Tepper, SJ | 1 |
| Keller, MB | 1 |
| Anaissie, E; Arndt, C; Donowitz, G; Finberg, R; Fioritoni, G; Garber, G; Greenberg, R; Hadley, S; Laverdière, M; Lazarus, HM; Lee, J; Pappas, P; Perfect, J; Petersen, F; Raffalli, J; Reboli, A; Reinhardt, J; Schuster, M; Stiff, P; Walsh, TJ; Wingard, J; Winston, DJ; Yanovich, S | 1 |
| Borian, FE; Crits-Christoph, P; Dunner, DL; Hirschfeld, RM; Keitner, G; Keller, MB; Klein, DN; Koran, LM; Kornstein, SG; Markowitz, JC; Miller, I; Nemeroff, CB; Ninan, PT; Rush, AJ; Schatzberg, AF; Thase, ME; Trivedi, MH | 1 |
| Bond, CM; Grimshaw, JM; Ludbrook, A; Mollison, J; Watson, MC | 1 |
| Keller, MB; Laird, LK; Prather, MR; Rush, AJ; Schatzberg, AF; Wright, CW | 1 |
| Bailey, L; Dunner, DL; Laird, LK; Seabolt, JL; Sussman, N; Zajecka, J | 1 |
| Borian, FE; Crits-Christoph, P; Keller, MB; Kornstein, SG; Manber, R; Ninan, PT; Rothbaum, BO; Rush, AJ; Thase, ME; Trivedi, MH; Zajecka, J | 1 |
| Borian, FE; Dunner, DL; Friedman, ES; Keller, MB; Klein, DN; Kornstein, SG; Manber, R; Markowitz, JC; Ninan, PT; Rush, AJ; Schatzberg, AF; Thase, ME; Trivedi, MH | 1 |
| Matsuzaki, M; Okuyama, D; Sekino, M; Tsuchida, M; Yoshida, A | 1 |
| Allcorn, RJ; Scudamore, JA; Tooley, PJ | 1 |
| Chao, W; Levine, BA; Olson, MS; Zhou, WG | 1 |
| Giers, G; Janzarik, H; Kempe, ER; Mueller-Eckhardt, C | 2 |
| Jonderko, G; Kita, I; Kita, K; Knapek, R; Kotulska, A; Lachowicz, K | 1 |
| Defaveri, J; Graybill, JR | 1 |
| Ban, TA; Galvan, L; Kussin, D; Nair, NP | 1 |
| Gunella, G; Melica, A; Serafini, F | 1 |
15 review(s) available for triazoles and Chronic Disease
| Article | Year |
|---|---|
Point of View: Electrophysiological Endpoints Differ When Comparing the Mode of Action of Highly Successful Anti-arrhythmic Drugs in the CAVB Dog Model With TdP.
Topics: Action Potentials; Aniline Compounds; Animals; Anti-Arrhythmia Agents; Atrioventricular Block; Chronic Disease; Disease Models, Animal; Dogs; Electrophysiologic Techniques, Cardiac; Endpoint Determination; Flunarizine; Heart Rate; Phenyl Ethers; Pyridines; Time Factors; Torsades de Pointes; Triazoles; Verapamil | 2019 |
Therapeutic Strategies for the Treatment of Chronic Hyperuricemia: An Evidence-Based Update.
Topics: Acetamides; Allopurinol; Benzbromarone; Chronic Disease; Evidence-Based Medicine; Febuxostat; Gout Suppressants; Humans; Hyperuricemia; Naphthalenes; Nitriles; Phenylacetates; Polyethylene Glycols; Probenecid; Propionates; Pyridines; Thioglycolates; Triazoles; Urate Oxidase; Uricosuric Agents; Xanthine Oxidase | 2021 |
Gout - An update of aetiology, genetics, co-morbidities and management.
Topics: Allopurinol; Chronic Disease; Comorbidity; Diet; Febuxostat; Gout; Gout Suppressants; Humans; Hyperuricemia; Probenecid; Thioglycolates; Triazoles; Uric Acid | 2018 |
[Invasive fungal rhinosinusitis in an apparently immunocompetant patient].
Topics: Aged; Antifungal Agents; Aortic Valve Stenosis; Aspergillosis; Chronic Disease; Female; Humans; Immunocompetence; Incidental Findings; Maxillary Sinusitis; Preoperative Care; Pyrimidines; Recurrence; Rhinitis; Triazoles; Voriconazole | 2013 |
Management of refractory typical GERD symptoms.
Topics: Alginates; Algorithms; Antacids; Baclofen; Chronic Disease; Esophagoscopy; Gastroesophageal Reflux; Gastrointestinal Agents; Gastroscopy; Humans; Isoxazoles; Muscle Relaxants, Central; Neurotransmitter Agents; Phosphinic Acids; Propylamines; Triazoles | 2016 |
Deferasirox for the treatment of iron overload associated with regular blood transfusions (transfusional haemosiderosis) in patients suffering with chronic anaemia: a systematic review and economic evaluation.
Topics: Anemia; Benzoates; Chronic Disease; Contraindications; Cost-Benefit Analysis; Deferasirox; Deferiprone; Deferoxamine; Drug Therapy, Combination; Hemosiderosis; Humans; Iron Chelating Agents; Pyridones; Randomized Controlled Trials as Topic; Technology Assessment, Biomedical; Transfusion Reaction; Treatment Outcome; Triazoles | 2009 |
Pharmacology of GLP-1 agonists: describing the therapeutic potential to patients.
Topics: Algorithms; Chronic Disease; Diabetes Mellitus, Type 2; Exenatide; Glucagon-Like Peptide 1; Glycated Hemoglobin; Humans; Hypoglycemic Agents; Incretins; Male; Middle Aged; Peptides; Pyrazines; Sitagliptin Phosphate; Triazoles; Venoms | 2011 |
Update in treatment of Chagas disease.
Topics: Chagas Disease; Chronic Disease; Humans; Immune Tolerance; Immunocompromised Host; Nitroimidazoles; Triazoles; Trypanocidal Agents; Trypanosoma cruzi | 2011 |
Deferasirox : a review of its use in the management of transfusional chronic iron overload.
Topics: Animals; Benzoates; Blood Transfusion; Chronic Disease; Deferasirox; Humans; Iron; Iron Chelating Agents; Iron Overload; Liver; Transfusion Reaction; Triazoles | 2007 |
New strategies for treating chronic depression.
Topics: Antidepressive Agents; Antidepressive Agents, Second-Generation; Chronic Disease; Clinical Trials as Topic; Cognitive Behavioral Therapy; Combined Modality Therapy; Depressive Disorder; Humans; Piperazines; Treatment Outcome; Triazoles | 2000 |
Acute and maintenance treatment of chronic depression.
Topics: Adult; Antidepressive Agents; Antidepressive Agents, Second-Generation; Chronic Disease; Cognitive Behavioral Therapy; Combined Modality Therapy; Depressive Disorder; Dysthymic Disorder; Humans; Multicenter Studies as Topic; Piperazines; Psychotherapy; Randomized Controlled Trials as Topic; Recurrence; Treatment Outcome; Triazoles | 2001 |
Oral versus intra-vaginal imidazole and triazole anti-fungal agents for the treatment of uncomplicated vulvovaginal candidiasis (thrush): a systematic review.
Topics: Acute Disease; Administration, Intravaginal; Administration, Oral; Antifungal Agents; Candidiasis, Vulvovaginal; Chronic Disease; Cost-Benefit Analysis; Female; Humans; Imidazoles; Patient Satisfaction; Randomized Controlled Trials as Topic; Triazoles | 2002 |
Clinical use of nefazodone in major depression: a 6-year perspective.
Topics: Age Factors; Antidepressive Agents, Second-Generation; Chronic Disease; Depressive Disorder; Hospitalization; Humans; Meta-Analysis as Topic; Piperazines; Randomized Controlled Trials as Topic; Secondary Prevention; Selective Serotonin Reuptake Inhibitors; Sleep; Triazoles | 2002 |
Six-year perspectives on the safety and tolerability of nefazodone.
Topics: Age Factors; Antidepressive Agents, Second-Generation; Body Weight; Chronic Disease; Depressive Disorder; Dose-Response Relationship, Drug; Female; Humans; Male; Obesity; Piperazines; Priapism; Seizures; Sexual Dysfunctions, Psychological; Suicide; Triazoles | 2002 |
The treatment of acute and chronic vaginal candidosis.
Topics: Acute Disease; Candidiasis, Vulvovaginal; Chronic Disease; Coloring Agents; Female; Humans; Imidazoles; Polyenes; Triazoles | 1992 |
38 trial(s) available for triazoles and Chronic Disease
| Article | Year |
|---|---|
Detecting critical decision points in psychotherapy and psychotherapy + medication for chronic depression.
Topics: Adult; Antidepressive Agents; Chronic Disease; Cognitive Behavioral Therapy; Combined Modality Therapy; Depressive Disorder, Major; Drug Administration Schedule; Female; Humans; Male; Middle Aged; Piperazines; Psychiatric Status Rating Scales; Remission Induction; Sensitivity and Specificity; Treatment Outcome; Triazoles | 2013 |
Randomized trial of posaconazole and benznidazole for chronic Chagas' disease.
Topics: Adult; Chagas Disease; Chronic Disease; DNA, Protozoan; Female; Humans; Intention to Treat Analysis; Male; Middle Aged; Nitroimidazoles; Prospective Studies; Transaminases; Treatment Outcome; Triazoles; Trypanocidal Agents; Trypanosoma cruzi | 2014 |
Benznidazole and Posaconazole in Eliminating Parasites in Asymptomatic T. Cruzi Carriers: The STOP-CHAGAS Trial.
Topics: Administration, Oral; Adult; Chagas Disease; Chronic Disease; Drug Therapy, Combination; Female; Humans; Male; Middle Aged; Nitroimidazoles; Prospective Studies; Single-Blind Method; Triazoles; Trypanocidal Agents; Trypanosoma cruzi | 2017 |
Patient preference as a moderator of outcome for chronic forms of major depressive disorder treated with nefazodone, cognitive behavioral analysis system of psychotherapy, or their combination.
Topics: Adult; Antidepressive Agents, Second-Generation; Chronic Disease; Cognitive Behavioral Therapy; Combined Modality Therapy; Depressive Disorder, Major; Female; Humans; Male; Middle Aged; Patient Participation; Personality Inventory; Piperazines; Triazoles | 2009 |
Select comorbid personality disorders and the treatment of chronic depression with nefazodone, targeted psychotherapy, or their combination.
Topics: Adaptation, Psychological; Adult; Antidepressive Agents, Second-Generation; Chronic Disease; Cognitive Behavioral Therapy; Combined Modality Therapy; Comorbidity; Culture; Depressive Disorder, Major; Dysthymic Disorder; Female; Humans; Male; Middle Aged; Personality Disorders; Personality Inventory; Piperazines; Problem Solving; Recurrence; Triazoles | 2009 |
Dyadic discord at baseline is associated with lack of remission in the acute treatment of chronic depression.
Topics: Adolescent; Adult; Aged; Antidepressive Agents, Second-Generation; Chronic Disease; Cognitive Behavioral Therapy; Combined Modality Therapy; Depressive Disorder, Major; Female; Humans; Male; Marriage; Middle Aged; Piperazines; Predictive Value of Tests; Psychiatric Status Rating Scales; Remission Induction; Self Disclosure; Treatment Outcome; Triazoles; Young Adult | 2010 |
Differential effects of treatments for chronic depression: a latent growth model reanalysis.
Topics: Adult; Antidepressive Agents, Second-Generation; Chronic Disease; Cognitive Behavioral Therapy; Combined Modality Therapy; Depressive Disorder, Major; Dysthymic Disorder; Female; Humans; Male; Middle Aged; Models, Psychological; Personality Inventory; Piperazines; Psychometrics; Secondary Prevention; Triazoles | 2010 |
Intravenous micafungin versus voriconazole for chronic pulmonary aspergillosis: a multicenter trial in Japan.
Topics: Aged; Aged, 80 and over; Antifungal Agents; Aspergillus; Chronic Disease; Echinocandins; Female; Humans; Infusions, Intravenous; Japan; Lipopeptides; Male; Micafungin; Microbial Sensitivity Tests; Middle Aged; Pulmonary Aspergillosis; Pyrimidines; Radiography; Treatment Outcome; Triazoles; Voriconazole | 2010 |
Intensification of antiretroviral therapy with a CCR5 antagonist in patients with chronic HIV-1 infection: effect on T cells latently infected.
Topics: Adult; Anti-HIV Agents; Antiretroviral Therapy, Highly Active; Bacteria; CCR5 Receptor Antagonists; CD8-Positive T-Lymphocytes; Chronic Disease; Cyclohexanes; Disease Reservoirs; DNA, Circular; Female; HIV Infections; HIV-1; Humans; Immunologic Memory; Lymphocyte Activation; Male; Maraviroc; Middle Aged; Plasmids; Receptors, CCR5; T-Lymphocyte Subsets; T-Lymphocytes; Triazoles; Viremia | 2011 |
Voriconazole for chronic pulmonary aspergillosis: a prospective multicenter trial.
Topics: Adult; Aged; Aged, 80 and over; Antifungal Agents; Aspergillus fumigatus; Chronic Disease; Drug-Related Side Effects and Adverse Reactions; Endoscopy; Female; Humans; Male; Middle Aged; Prospective Studies; Pulmonary Aspergillosis; Pyrimidines; Radiography, Thoracic; Tomography, X-Ray Computed; Treatment Outcome; Triazoles; Voriconazole | 2012 |
Sexual function and satisfaction in the treatment of chronic major depression with nefazodone, psychotherapy, and their combination.
Topics: Adult; Antidepressive Agents, Second-Generation; Attitude to Health; Chronic Disease; Cognitive Behavioral Therapy; Combined Modality Therapy; Depressive Disorder; Female; Humans; Male; Personal Satisfaction; Piperazines; Psychiatric Status Rating Scales; Sex Factors; Sexual Behavior; Sexual Dysfunctions, Psychological; Treatment Outcome; Triazoles | 2002 |
The effects of psychotherapy, nefazodone, and their combination on subjective assessment of disturbed sleep in chronic depression.
Topics: Adolescent; Adult; Aged; Antidepressive Agents, Second-Generation; Chronic Disease; Combined Modality Therapy; Depressive Disorder, Major; Female; Humans; Male; Middle Aged; Piperazines; Psychotherapy; Severity of Illness Index; Sleep Wake Disorders; Triazoles | 2003 |
The effect of nefazodone on subjective and objective sleep quality in posttraumatic stress disorder.
Topics: Antidepressive Agents, Second-Generation; Chronic Disease; Drug Administration Schedule; Humans; Male; Middle Aged; Piperazines; Polysomnography; Psychiatric Status Rating Scales; Sleep; Stress Disorders, Post-Traumatic; Surveys and Questionnaires; Treatment Outcome; Triazoles; Veterans | 2003 |
Efficacy of nefazodone in the treatment of neuroleptic induced extrapyramidal side effects: a double-blind randomised parallel group placebo-controlled trial.
Topics: Acute Disease; Antidepressive Agents, Second-Generation; Antipsychotic Agents; Basal Ganglia Diseases; Chronic Disease; Double-Blind Method; Female; Haloperidol; Humans; Male; Piperazines; Receptors, Serotonin, 5-HT2; Schizophrenia; Serotonin Antagonists; Substance-Related Disorders; Triazoles | 2003 |
Patient's therapeutic skill acquisition and response to psychotherapy, alone or in combination with medication.
Topics: Adolescent; Adult; Aged; Antidepressive Agents, Second-Generation; Chronic Disease; Cognitive Behavioral Therapy; Combined Modality Therapy; Depressive Disorder, Major; Female; Humans; Interpersonal Relations; Learning; Male; Middle Aged; Piperazines; Psychiatric Status Rating Scales; Treatment Outcome; Triazoles | 2003 |
Randomized, placebo-controlled trial of nefazodone maintenance treatment in preventing recurrence in chronic depression.
Topics: Acute Disease; Adolescent; Adult; Aged; Antidepressive Agents, Second-Generation; Chronic Disease; Combined Modality Therapy; Cross-Over Studies; Depressive Disorder, Major; Double-Blind Method; Eligibility Determination; Female; Humans; Male; Middle Aged; Piperazines; Psychotherapy; Recurrence; Substance Withdrawal Syndrome; Triazoles | 2003 |
Differential responses to psychotherapy versus pharmacotherapy in patients with chronic forms of major depression and childhood trauma.
Topics: Adolescent; Adult; Aged; Antidepressive Agents, Second-Generation; Child; Child Abuse; Chronic Disease; Cognitive Behavioral Therapy; Cohort Studies; Combined Modality Therapy; Depressive Disorder, Major; Female; Humans; Male; Middle Aged; Piperazines; Triazoles | 2003 |
Continuation treatment of chronic depression: a comparison of nefazodone, cognitive behavioral analysis system of psychotherapy, and their combination.
Topics: Adolescent; Adult; Aged; Antidepressive Agents, Second-Generation; Chronic Disease; Cognitive Behavioral Therapy; Combined Modality Therapy; Depressive Disorder, Major; Female; Humans; Male; Middle Aged; Observer Variation; Piperazines; Triazoles | 2003 |
Self-reported depressive symptom measures: sensitivity to detecting change in a randomized, controlled trial of chronically depressed, nonpsychotic outpatients.
Topics: Adolescent; Adult; Aged; Antidepressive Agents, Second-Generation; Chronic Disease; Cognitive Behavioral Therapy; Combined Modality Therapy; Depressive Disorder; Female; Humans; Male; Middle Aged; Outpatients; Piperazines; Psychiatric Status Rating Scales; Self-Assessment; Treatment Outcome; Triazoles | 2005 |
Chronic depression: medication (nefazodone) or psychotherapy (CBASP) is effective when the other is not.
Topics: Adult; Antidepressive Agents, Second-Generation; Chronic Disease; Cognitive Behavioral Therapy; Cross-Over Studies; Depressive Disorder, Major; Female; Humans; Male; Piperazines; Psychiatric Status Rating Scales; Regression Analysis; Survival Analysis; Treatment Outcome; Triazoles | 2005 |
Voriconazole treatment for subacute invasive and chronic pulmonary aspergillosis.
Topics: Adult; Amphotericin B; Antifungal Agents; Aspergillosis; Chronic Disease; Drug Administration Schedule; Female; Humans; Itraconazole; Lung Diseases, Fungal; Male; Middle Aged; Pyrimidines; Salvage Therapy; Treatment Failure; Treatment Outcome; Triazoles; Voriconazole | 2006 |
Dropouts versus completers among chronically depressed outpatients.
Topics: Adolescent; Adult; Aged; Ambulatory Care; Antidepressive Agents, Second-Generation; Anxiety Disorders; Chronic Disease; Cognitive Behavioral Therapy; Combined Modality Therapy; Comorbidity; Depressive Disorder, Major; Female; Humans; Male; Middle Aged; Patient Dropouts; Physician-Patient Relations; Piperazines; Risk Factors; Triazoles | 2007 |
Treatment of chronic pulmonary aspergillosis by voriconazole in nonimmunocompromised patients.
Topics: Adult; Aged; Antifungal Agents; Aspergillosis, Allergic Bronchopulmonary; Chronic Disease; Cohort Studies; Dose-Response Relationship, Drug; Female; Follow-Up Studies; Humans; Immunocompetence; Lung; Male; Middle Aged; Pyrimidines; Retrospective Studies; Triazoles; Voriconazole | 2007 |
Posaconazole therapy for chronic refractory coccidioidomycosis.
Topics: Administration, Oral; Adult; Aged; Antifungal Agents; Chronic Disease; Coccidioidomycosis; Dose-Response Relationship, Drug; Drug Administration Schedule; Female; Humans; Male; Middle Aged; Treatment Outcome; Triazoles | 2007 |
Pharmacokinetics of oral posaconazole in allogeneic hematopoietic stem cell transplant recipients with graft-versus-host disease.
Topics: Acute Disease; Adolescent; Adult; Age Factors; Aged; Antifungal Agents; Body Weight; Chronic Disease; Diarrhea; Double-Blind Method; Female; Graft vs Host Disease; Hematopoietic Stem Cell Transplantation; Humans; Male; Middle Aged; Mycoses; Opportunistic Infections; Racial Groups; Sex Factors; Transplantation, Homologous; Triazoles | 2007 |
Long-term treatment of depression with nefazodone.
Topics: Antidepressive Agents; Chronic Disease; Depressive Disorder; Double-Blind Method; Humans; Imipramine; Piperazines; Triazoles | 1994 |
Topical R-85355, a potent and selective 5-lipoxygenase inhibitor, fails to improve psoriasis.
Topics: Administration, Topical; Adult; Chronic Disease; Double-Blind Method; Female; Humans; Lipoxygenase Inhibitors; Male; Middle Aged; Piperazines; Prospective Studies; Psoriasis; Triazoles | 1996 |
Nefazodone treatment and dream reports in chronic PTSD.
Topics: Aged; Antidepressive Agents, Second-Generation; Chronic Disease; Combat Disorders; Dreams; Female; Humans; Male; Middle Aged; Piperazines; Sleep, REM; Triazoles | 1999 |
Nefazodone treatment for chronic posttraumatic stress disorder: an open trial.
Topics: Adult; Aged; Antidepressive Agents, Second-Generation; Chronic Disease; Combat Disorders; Female; Humans; Male; Middle Aged; Personality Inventory; Piperazines; Stress Disorders, Post-Traumatic; Treatment Outcome; Triazoles; Veterans | 2000 |
A comparison of nefazodone, the cognitive behavioral-analysis system of psychotherapy, and their combination for the treatment of chronic depression.
Topics: Adult; Antidepressive Agents, Second-Generation; Behavior Therapy; Chronic Disease; Cognitive Behavioral Therapy; Combined Modality Therapy; Depressive Disorder; Female; Humans; Male; Piperazines; Treatment Outcome; Triazoles | 2000 |
Nefazodone in patients with treatment-refractory posttraumatic stress disorder.
Topics: Ambulatory Care; Antidepressive Agents, Second-Generation; Chronic Disease; Circadian Rhythm; Combat Disorders; Comorbidity; Drug Administration Schedule; Drug Resistance; Humans; Male; Mental Disorders; Piperazines; Psychiatric Status Rating Scales; Severity of Illness Index; Sexual Behavior; Sleep; Social Adjustment; Stress Disorders, Post-Traumatic; Triazoles; Veterans | 2000 |
Does nefazadone alone, the cognitive behavioral-analysis system of psychotherapy, or the combination of both work best for patients with chronic depression?
Topics: Adult; Aged; Antidepressive Agents, Second-Generation; Behavior Therapy; Chronic Disease; Cognitive Behavioral Therapy; Combined Modality Therapy; Depressive Disorder; Humans; Middle Aged; Piperazines; Triazoles | 2000 |
Nefazodone for chronic daily headache prophylaxis: an open-label study.
Topics: Adolescent; Adult; Analgesics; Child; Chronic Disease; Female; Headache; Humans; Male; Medical Records; Middle Aged; Piperazines; Triazoles | 2001 |
Voriconazole compared with liposomal amphotericin B for empirical antifungal therapy in patients with neutropenia and persistent fever.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Amphotericin B; Anti-Bacterial Agents; Antifungal Agents; Chemical and Drug Induced Liver Injury; Child; Chronic Disease; Female; Fever; Humans; Infusions, Intravenous; Male; Middle Aged; Mycoses; Neoplasms; Neutropenia; Prospective Studies; Pyrimidines; Triazoles; Voriconazole | 2002 |
Does psychosocial functioning improve independent of depressive symptoms? A comparison of nefazodone, psychotherapy, and their combination.
Topics: Adult; Antidepressive Agents, Second-Generation; Chronic Disease; Cognitive Behavioral Therapy; Combined Modality Therapy; Depressive Disorder, Major; Female; Humans; Male; Middle Aged; Piperazines; Social Adjustment; Treatment Outcome; Triazoles | 2002 |
Symptomatic and syndromal anxiety in chronic forms of major depression: effect of nefazodone, cognitive behavioral analysis system of psychotherapy, and their combination.
Topics: Adult; Antidepressive Agents, Second-Generation; Anxiety Disorders; Chronic Disease; Cognitive Behavioral Therapy; Combined Modality Therapy; Comorbidity; Depressive Disorder; Drug Administration Schedule; Female; Humans; Male; Piperazines; Psychiatric Status Rating Scales; Treatment Outcome; Triazoles | 2002 |
Differential effects of nefazodone and cognitive behavioral analysis system of psychotherapy on insomnia associated with chronic forms of major depression.
Topics: Adult; Antidepressive Agents, Second-Generation; Chronic Disease; Cognitive Behavioral Therapy; Combined Modality Therapy; Depressive Disorder; Drug Administration Schedule; Female; Humans; Linear Models; Male; Outcome Assessment, Health Care; Personality Inventory; Piperazines; Sleep Initiation and Maintenance Disorders; Treatment Outcome; Triazoles | 2002 |
Trazodone in the treatment of schizophrenias.
Topics: Antidepressive Agents; Chronic Disease; Clinical Trials as Topic; Female; Humans; Male; Middle Aged; Piperazines; Placebos; Psychiatric Status Rating Scales; Pyridines; Schizophrenia; Time Factors; Tranquilizing Agents; Triazoles | 1973 |
79 other study(ies) available for triazoles and Chronic Disease
| Article | Year |
|---|---|
Blockade of adenosine A
Topics: Adenosine A2 Receptor Antagonists; Animals; Brain-Derived Neurotrophic Factor; Caspase 3; Chronic Disease; Cognition Disorders; Cognitive Dysfunction; Hippocampus; Hypoxia, Brain; Long-Term Potentiation; Male; Maze Learning; Mice; Mice, Inbred C57BL; Mice, Knockout; Proto-Oncogene Proteins c-bcl-2; Psychomotor Performance; Pyrimidines; Receptor, Adenosine A2A; Triazoles | 2022 |
Challenging diagnosis of chronic cerebral fungal infection: Value of (1→3)-ß-D-glucan and mannan antigen testing in cerebrospinal fluid and of cerebral ventricle puncture.
Topics: Adult; Aged; Amphotericin B; Antifungal Agents; Antigens, Fungal; beta-Glucans; Biomarkers; Central Nervous System Fungal Infections; Cerebrospinal Fluid; Chronic Disease; Diagnostic Tests, Routine; Female; Healthy Volunteers; Humans; Male; Mannans; Middle Aged; Retrospective Studies; Treatment Outcome; Triazoles | 2021 |
Chronic Disease Approaches Needed to Curb Gout's Growing Burden.
Topics: Allopurinol; Chronic Disease; Diet; Drug Combinations; Febuxostat; Gout; Gout Suppressants; Healthy Lifestyle; Humans; Patient Education as Topic; Practice Guidelines as Topic; Purines; Thioglycolates; Triazoles; Uric Acid | 2018 |
Cost-effectiveness analysis of suvorexant for the treatment of Japanese elderly patients with chronic insomnia in a virtual cohort.
Topics: Aged; Aged, 80 and over; Azepines; Chronic Disease; Computer Simulation; Cost-Benefit Analysis; Female; Hip Fractures; Humans; Hypnotics and Sedatives; Japan; Male; Models, Econometric; Pyridines; Quality-Adjusted Life Years; Sleep Initiation and Maintenance Disorders; Triazoles; Zolpidem | 2018 |
Assessment of posaconazole salvage therapy in chronic pulmonary aspergillosis using predefined response criteria.
Topics: Adult; Aged; Aged, 80 and over; Antifungal Agents; Aspergillus fumigatus; Chronic Disease; Female; Humans; Male; Middle Aged; Pulmonary Aspergillosis; Retrospective Studies; Salvage Therapy; Surveys and Questionnaires; Survival Analysis; Treatment Outcome; Triazoles | 2018 |
Candida auris Sternal Osteomyelitis in a Man from Kenya Visiting Australia, 2015.
Topics: Aged; Antifungal Agents; Australia; Bone and Bones; Candida; Candidiasis; Chronic Disease; Fatal Outcome; Humans; Kenya; Male; Osteomyelitis; Tomography, X-Ray Computed; Travel; Triazoles; Whole Genome Sequencing | 2019 |
Isavuconazole and voriconazole for the treatment of chronic pulmonary aspergillosis: A retrospective comparison of rates of adverse events.
Topics: Adult; Aged; Aged, 80 and over; Antifungal Agents; Chronic Disease; Drug-Related Side Effects and Adverse Reactions; Female; Humans; Male; Middle Aged; Nitriles; Pulmonary Aspergillosis; Pyridines; Retrospective Studies; Triazoles; United Kingdom; Voriconazole | 2019 |
Therapeutic drug monitoring and adverse events of delayed-release posaconazole tablets in patients with chronic pulmonary aspergillosis.
Topics: Administration, Oral; Adult; Aged; Antifungal Agents; Chronic Disease; Delayed-Action Preparations; Drug Monitoring; Female; Humans; Male; Middle Aged; Pulmonary Aspergillosis; Tablets; Treatment Outcome; Triazoles | 2019 |
Lobomycosis successfully treated with posaconazole.
Topics: Adult; Chronic Disease; Follow-Up Studies; Humans; Lacazia; Lobomycosis; Male; Peru; Recurrence; Treatment Outcome; Triazoles | 2013 |
Turning a blind eye to deferasirox's toxicity?
Topics: Age Factors; Benzoates; Cause of Death; Chronic Disease; Deferasirox; Drug Approval; Europe; Hematologic Diseases; Humans; Iron Chelating Agents; Iron Overload; Triazoles | 2013 |
Preventing graft-versus-host disease: transplanters glimpse hope beyond immunosuppressants.
Topics: Acute Disease; Bone Marrow Transplantation; Boronic Acids; Bortezomib; Chronic Disease; Clinical Trials as Topic; Cyclohexanes; Cyclophosphamide; Cyclosporine; Evidence-Based Medicine; Graft vs Host Disease; Hematopoietic Stem Cell Transplantation; Humans; Hydroxamic Acids; Immunosuppressive Agents; Maraviroc; Methotrexate; Pentostatin; Peripheral Blood Stem Cell Transplantation; Pyrazines; Quality of Life; Tacrolimus; Triazoles; Vorinostat | 2013 |
Perplexity of a fungus in the sinus.
Topics: Adolescent; Amphotericin B; Antifungal Agents; Ascomycota; Benzenesulfonates; Brain Abscess; Central Nervous System Fungal Infections; Chronic Disease; Coloring Agents; Debridement; Epidural Abscess; Frontal Lobe; Frontal Sinus; Humans; Lactic Acid; Male; Phenols; Pyrimidines; Sinusitis; Treatment Outcome; Triazoles; Voriconazole | 2014 |
Chronic granulomatous invasive fungal sinusitis: an evolving approach to management.
Topics: Adult; Amphotericin B; Antifungal Agents; Aspergillosis; Aspergillus fumigatus; Chronic Disease; Granuloma; Humans; Male; Pyrimidines; Sinusitis; Triazoles; Voriconazole | 2014 |
Epidemiology, management, and outcome of invasive fungal disease in patients undergoing hematopoietic stem cell transplantation in China: a multicenter prospective observational study.
Topics: Adolescent; Adult; Antifungal Agents; China; Chronic Disease; Female; Graft vs Host Disease; Hematologic Neoplasms; Hematopoietic Stem Cell Transplantation; Humans; Immunosuppressive Agents; Incidence; Male; Mycoses; Myeloablative Agonists; Neutropenia; Prognosis; Prospective Studies; Risk Factors; Siblings; Survival Analysis; Transplantation Conditioning; Transplantation, Autologous; Transplantation, Homologous; Treatment Outcome; Triazoles; Unrelated Donors | 2015 |
Limited Ability of Posaconazole To Cure both Acute and Chronic Trypanosoma cruzi Infections Revealed by Highly Sensitive In Vivo Imaging.
Topics: Animals; Antifungal Agents; Chagas Disease; Chronic Disease; Disease Models, Animal; Female; Mice; Mice, Inbred BALB C; Mice, SCID; Nitroimidazoles; Triazoles; Trypanocidal Agents; Trypanosoma cruzi | 2015 |
Beneficial properties of maraviroc on neuropathic pain development and opioid effectiveness in rats.
Topics: Analgesics, Opioid; Animals; Astrocytes; Buprenorphine; CCR5 Receptor Antagonists; Cells, Cultured; Chronic Disease; Cyclohexanes; Cytokines; Disease Models, Animal; Drug Synergism; Ganglia, Spinal; Hyperalgesia; Lipopolysaccharides; Male; Maraviroc; Microglia; Morphine; Neuralgia; Rats, Wistar; Sciatic Nerve; Spinal Cord; Triazoles | 2016 |
Drug Susceptibility of Genetically Engineered Trypanosoma cruzi Strains and Sterile Cure in Animal Models as a Criterion for Potential Clinical Efficacy of Anti-T. cruzi Drugs.
Topics: Animals; Antifungal Agents; Chagas Disease; Chronic Disease; Female; Triazoles; Trypanocidal Agents; Trypanosoma cruzi | 2015 |
Reply to "Drug Susceptibility of Genetically Engineered Trypanosoma cruzi Strains and Sterile Cure in Animal Models as a Criterion for Potential Clinical Efficacy of Anti-T. cruzi Drugs".
Topics: Animals; Antifungal Agents; Chagas Disease; Chronic Disease; Female; Triazoles; Trypanocidal Agents; Trypanosoma cruzi | 2015 |
Oral Azole Antifungal Medications and Risk of Acute Liver Injury, Overall and by Chronic Liver Disease Status.
Topics: Administration, Oral; Adult; Antifungal Agents; California; Chemical and Drug Induced Liver Injury; Chronic Disease; Cohort Studies; Female; Humans; Liver Diseases; Liver Failure, Acute; Male; Middle Aged; Retrospective Studies; Transaminases; Triazoles | 2016 |
The Effect of A2A Receptor Antagonist on Microglial Activation in Experimental Glaucoma.
Topics: Adenosine A2 Receptor Antagonists; Animals; Blotting, Western; Cell Count; Cells, Cultured; Chronic Disease; Cytokines; Disease Models, Animal; Enzyme-Linked Immunosorbent Assay; Flow Cytometry; Glaucoma; Immunohistochemistry; Intravitreal Injections; Male; Microglia; Ocular Hypertension; Rats; Rats, Sprague-Dawley; Real-Time Polymerase Chain Reaction; Retinal Ganglion Cells; RNA; Triazines; Triazoles | 2016 |
Posaconazole Substitution for Voriconazole-Associated Phototoxic Effects.
Topics: Aged; Antifungal Agents; Chronic Disease; Dermatitis, Phototoxic; Exophiala; Female; Follow-Up Studies; Humans; Meningitis, Fungal; Phaeohyphomycosis; Retreatment; Risk Assessment; Treatment Outcome; Triazoles; Voriconazole | 2016 |
Predictors of mortality in chronic pulmonary aspergillosis.
Topics: Adolescent; Adult; Age Factors; Aged; Aged, 80 and over; C-Reactive Protein; Chronic Disease; Female; Humans; Lung; Male; Middle Aged; Mycobacterium Infections, Nontuberculous; Prognosis; Pulmonary Aspergillosis; Pulmonary Disease, Chronic Obstructive; Quality of Life; Retrospective Studies; Risk Factors; Serum Albumin, Human; Survival Analysis; Triazoles; United Kingdom; Young Adult | 2017 |
Faster remission of chronic depression with combined psychotherapy and medication than with each therapy alone.
Topics: Adolescent; Adult; Aged; Antidepressive Agents; Anxiety Disorders; Chronic Disease; Cognitive Behavioral Therapy; Combined Modality Therapy; Depressive Disorder, Major; Female; Humans; Male; Middle Aged; Piperazines; Psychiatric Status Rating Scales; Remission Induction; ROC Curve; Severity of Illness Index; Time Factors; Triazoles | 2008 |
[Chronic necrotizing aspergillosis].
Topics: Antifungal Agents; Aspergillosis; Bronchoalveolar Lavage; Chronic Disease; Cough; Female; Fever; Humans; Lung Diseases, Fungal; Middle Aged; Necrosis; Pyrimidines; Triazoles; Voriconazole | 2008 |
[Case of an HTLV-1 carrier complicated with chronic pulmonary histoplasmosis].
Topics: Antibodies, Fungal; Antibodies, Viral; Antifungal Agents; Carrier State; Chronic Disease; Histoplasma; Histoplasmosis; HTLV-I Infections; Human T-lymphotropic virus 1; Humans; Immunodiffusion; Lung Diseases, Fungal; Male; Middle Aged; Pyrimidines; Serologic Tests; Tomography, X-Ray Computed; Treatment Outcome; Triazoles; Voriconazole | 2008 |
[Clinical features of chronic necrotizing pulmonary aspergillosis treated with voriconazole in patients with chronic respiratory disease].
Topics: Adult; Aged; Aged, 80 and over; Aspergillosis; Chronic Disease; Female; Humans; Lung Diseases, Fungal; Male; Middle Aged; Pyrimidines; Respiratory Tract Diseases; Treatment Outcome; Triazoles; Voriconazole | 2008 |
Successful treatment of refractory endometriosis-related chronic pelvic pain with aromatase inhibitors in premenopausal patients.
Topics: Adult; Anastrozole; Aromatase Inhibitors; Chronic Disease; Dose-Response Relationship, Drug; Endometriosis; Estradiol; Female; Follicle Stimulating Hormone; Humans; Letrozole; Luteinizing Hormone; Nitriles; Pelvic Pain; Premenopause; Treatment Outcome; Triazoles; Uterine Diseases | 2009 |
[Painful peripheral neuropathy associated with voriconazole during the treatment of chronic cavitary pulmonary aspergillosis].
Topics: Aged; Antifungal Agents; Aspergillosis, Allergic Bronchopulmonary; Chronic Disease; Humans; Male; Pain; Peripheral Nervous System Diseases; Pyrimidines; Treatment Outcome; Triazoles; Voriconazole | 2010 |
Cannabidiol ameliorates cognitive and motor impairments in mice with bile duct ligation.
Topics: Adenosine A2 Receptor Antagonists; Animals; Bile Ducts; Brain-Derived Neurotrophic Factor; Cannabidiol; Chronic Disease; Cognition; Cognition Disorders; Cyclooxygenase 2; Disease Models, Animal; Female; Gait Disorders, Neurologic; Hepatic Encephalopathy; Ligation; Liver Diseases; Mice; Mice, Inbred Strains; Motor Activity; Receptor, Adenosine A2A; Receptors, Tumor Necrosis Factor, Type I; RNA, Messenger; Treatment Outcome; Triazines; Triazoles | 2009 |
A newly developed lung nodule during chemotherapy for small cell lung cancer. Chronic necrotising pulmonary aspergillosis.
Topics: Aged; Antifungal Agents; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Chronic Disease; Etoposide; Humans; Lung Neoplasms; Male; Pulmonary Aspergillosis; Pyrimidines; Small Cell Lung Carcinoma; Triazoles; Voriconazole | 2009 |
Melanoma associated with long-term voriconazole therapy: a new manifestation of chronic photosensitivity.
Topics: Adult; Antifungal Agents; Biopsy; Chronic Disease; Coccidioidomycosis; Diagnosis, Differential; Ear; Female; Follow-Up Studies; Forearm; Granulomatous Disease, Chronic; Humans; Male; Melanoma; Meningitis, Fungal; Photosensitivity Disorders; Pyrimidines; Skin Neoplasms; Time Factors; Triazoles; Voriconazole; Young Adult | 2010 |
Effect of iron chelator deferasirox on chronic anemia and thrombocytopenia in a transfusion-dependent patient with myelodysplastic syndrome.
Topics: Aged; Anemia; Benzoates; Chronic Disease; Deferasirox; Female; Humans; Iron Chelating Agents; Iron Overload; Myelodysplastic Syndromes; Radiography; Thrombocytopenia; Transfusion Reaction; Triazoles | 2010 |
Chronic necrotizing and allergic bronchopulmonary aspergillosis in an asthmatic patient--a therapeutic challenge.
Topics: Administration, Inhalation; Adrenal Cortex Hormones; Adult; Antifungal Agents; Aspergillosis, Allergic Bronchopulmonary; Aspergillus fumigatus; Asthma; Bronchoscopy; Caspofungin; Chronic Disease; Drug Therapy, Combination; Echinocandins; Female; Humans; Invasive Pulmonary Aspergillosis; Lipopeptides; Prognosis; Pyrimidines; Radiography, Thoracic; Recurrence; Risk Assessment; Severity of Illness Index; Tomography, X-Ray Computed; Treatment Outcome; Triazoles; Voriconazole | 2008 |
Acute renal failure and Fanconi syndrome due to deferasirox.
Topics: Acute Kidney Injury; Aged; Benzoates; Chronic Disease; Deferasirox; Fanconi Syndrome; Humans; Iron Chelating Agents; Iron Overload; Kidney; Male; Triazoles | 2010 |
Successful treatment of chronic stromal acanthamoeba keratitis with oral voriconazole monotherapy.
Topics: Acanthamoeba Keratitis; Administration, Oral; Adolescent; Antiprotozoal Agents; Chronic Disease; Corneal Stroma; Female; Humans; Male; Pyrimidines; Triazoles; Voriconazole | 2010 |
Chagas disease: pushing through the pipeline.
Topics: Adult; Animals; Chagas Disease; Child; Chronic Disease; Clinical Trials as Topic; Drug Evaluation, Preclinical; Female; Humans; Infant, Newborn; Lupus Erythematosus, Systemic; Molecular Targeted Therapy; Nitroimidazoles; Triazoles; Trypanocidal Agents; Trypanosoma cruzi; Young Adult | 2010 |
Efficacy and safety of posaconazole for chronic pulmonary aspergillosis.
Topics: Adult; Aged; Aged, 80 and over; Antibodies, Fungal; Antifungal Agents; Aspergillus; Chronic Disease; Female; Humans; Lung; Male; Microbial Sensitivity Tests; Middle Aged; Pulmonary Aspergillosis; Radiography, Thoracic; Retrospective Studies; Serum; Treatment Failure; Treatment Outcome; Triazoles | 2010 |
High-frequency triazole resistance found In nonculturable Aspergillus fumigatus from lungs of patients with chronic fungal disease.
Topics: Antifungal Agents; Aspergillosis, Allergic Bronchopulmonary; Aspergillus fumigatus; Bronchoalveolar Lavage Fluid; Chronic Disease; Culture Media; DNA, Fungal; Drug Resistance, Fungal; Humans; Invasive Pulmonary Aspergillosis; Lung; Mutation; Polymerase Chain Reaction; Pulmonary Aspergillosis; Sputum; Triazoles | 2011 |
Peripheral neuropathy in patients on long-term triazole antifungal therapy.
Topics: Adult; Aged; Antifungal Agents; Aspergillosis; Chronic Disease; Cohort Studies; Female; Humans; Itraconazole; Long-Term Care; Male; Middle Aged; Peripheral Nervous System Diseases; Pyrimidines; Retrospective Studies; Triazoles; Voriconazole; Young Adult | 2011 |
Posaconazole for chronic refractory coccidioidal meningitis.
Topics: Adolescent; Adult; Antifungal Agents; Chronic Disease; Coccidioides; Coccidioidomycosis; Humans; Male; Meningitis, Fungal; Treatment Outcome; Triazoles; Young Adult | 2011 |
Long-term survival in an untreated patient with leptomeningeal carcinomatosis from breast primary.
Topics: Antineoplastic Agents; Breast Neoplasms; Chronic Disease; Female; Humans; Hypesthesia; Immunohistochemistry; Letrozole; Magnetic Resonance Imaging; Meningeal Carcinomatosis; Middle Aged; Neural Conduction; Nitriles; Spinal Neoplasms; Survival; Triazoles | 2013 |
Frequency of fungal isolation and antifungal susceptibility pattern of the fungal isolates from nasal polyps of chronic rhinosinusitis patients at a tertiary care centre in north India.
Topics: Adult; Amphotericin B; Antifungal Agents; Aspergillosis; Chronic Disease; Female; Fungi; Humans; Immunoglobulin E; Incidence; India; Itraconazole; Male; Middle Aged; Mucins; Mycoses; Nasal Polyps; Pyrimidines; Retrospective Studies; Rhinitis, Allergic, Perennial; Sinusitis; Tertiary Healthcare; Tomography, X-Ray Computed; Triazoles; Voriconazole | 2013 |
Efficacy and safety of voriconazole in the treatment of chronic pulmonary aspergillosis: experience in Japan.
Topics: Aged; Antifungal Agents; Chronic Disease; Dose-Response Relationship, Drug; Female; Humans; Japan; Male; Middle Aged; Prospective Studies; Pulmonary Aspergillosis; Pyrimidines; Treatment Outcome; Triazoles; Voriconazole | 2012 |
Major variations in Aspergillus fumigatus arising within aspergillomas in chronic pulmonary aspergillosis.
Topics: Adult; Antifungal Agents; Aspergillus fumigatus; Chronic Disease; Female; Genetic Variation; Humans; Itraconazole; Microbial Sensitivity Tests; Microsatellite Repeats; Middle Aged; Molecular Typing; Mycological Typing Techniques; Pulmonary Aspergillosis; Pyrimidines; Triazoles; Voriconazole | 2013 |
Parasitological cure of acute and chronic experimental Chagas disease using the long-acting experimental triazole TAK-187. Activity against drug-resistant Trypanosoma cruzi strains.
Topics: Acute Disease; Animals; Chagas Disease; Chronic Disease; Dose-Response Relationship, Drug; Drug Resistance; Female; Mice; Triazoles; Trypanocidal Agents | 2003 |
Three- to four-year follow-up to an open trial of nefazodone for combat-related posttraumatic stress disorder.
Topics: Adult; Anger; Antidepressive Agents, Second-Generation; Chronic Disease; Clinical Trials as Topic; Combat Disorders; Depressive Disorder, Major; Follow-Up Studies; Humans; Male; Middle Aged; Middle East; Patient Compliance; Piperazines; Sleep; Treatment Outcome; Triazoles; Veterans | 2002 |
Successful treatment of concomitant pulmonary zygomycosis and aspergillosis with a combination of amphotericin B lipid complex, caspofungin, and voriconazole in a patient on immunosuppression for chronic graft-versus-host disease.
Topics: Amphotericin B; Antifungal Agents; Aspergillosis; Caspofungin; Chronic Disease; Drug Therapy, Combination; Echinocandins; Female; Graft vs Host Disease; Hematopoietic Stem Cell Transplantation; Humans; Immunosuppressive Agents; Lipopeptides; Lung; Middle Aged; Peptides, Cyclic; Pyrimidines; Tomography, X-Ray Computed; Transplantation, Homologous; Treatment Outcome; Triazoles; Voriconazole; Zygomycosis | 2004 |
Successful treatment of chronic meningitis caused by Scedosporium apiospermum with oral voriconazole.
Topics: Administration, Oral; Antifungal Agents; Chronic Disease; Female; Humans; Meningitis, Fungal; Middle Aged; Mycetoma; Pyrimidines; Scedosporium; Triazoles; Voriconazole | 2004 |
Apafant, a potent platelet-activating factor antagonist, blocks eosinophil activation and is effective in the chronic phase of experimental allergic conjunctivitis in guinea pigs.
Topics: Administration, Topical; Animals; Azepines; Chronic Disease; Conjunctiva; Conjunctivitis, Allergic; Dose-Response Relationship, Drug; Eosinophil Peroxidase; Eosinophils; Guinea Pigs; Male; Ophthalmic Solutions; Ovalbumin; Platelet Activating Factor; Tears; Triazoles | 2004 |
Voriconazole proves effective in long-term treatment of a cerebral cryptococcoma in a chronic nephropathic HIV-negative patient, after fluconazole failure.
Topics: Antifungal Agents; Brain Abscess; Chronic Disease; Cryptococcus neoformans; Fluconazole; HIV Seronegativity; Humans; Male; Meningitis, Cryptococcal; Middle Aged; Pyrimidines; Renal Insufficiency; Time Factors; Treatment Failure; Treatment Outcome; Triazoles; Voriconazole | 2004 |
The efficacy and tolerability of voriconazole in the treatment of chronic cavitary pulmonary aspergillosis.
Topics: Antifungal Agents; Aspergillosis; Chronic Disease; Female; Humans; Lung Diseases, Fungal; Male; Middle Aged; Pyrimidines; Retrospective Studies; Triazoles; Voriconazole | 2006 |
Chronic endophthalmitis due to verticillium species after cataract surgery treated (or managed) with pars plana vitrectomy and oral and intravitreal voriconazole.
Topics: Administration, Oral; Antifungal Agents; Chronic Disease; Combined Modality Therapy; Endophthalmitis; Eye Infections, Fungal; Humans; Injections; Lens Implantation, Intraocular; Male; Middle Aged; Mitosporic Fungi; Mycoses; Phacoemulsification; Postoperative Complications; Pyrimidines; Triazoles; Vitrectomy; Vitreous Body; Voriconazole | 2006 |
Chronic refractory phaeohyphomycosis: successful treatment with posaconazole.
Topics: Adolescent; Adult; Alternaria; Amphotericin B; Antifungal Agents; Chronic Disease; Deoxycholic Acid; Drug Combinations; Female; Humans; Mouth Diseases; Mycoses; Treatment Outcome; Triazoles | 2006 |
Quinupristin/dalfopristin and voriconazole controlled Staphylococcus epidermidis pneumonia and chronic necrotizing aspergillosis in a patient with severe lung degradation consequent to multiple treatments for Hodgkin's lymphoma.
Topics: Adult; Anti-Bacterial Agents; Antifungal Agents; Aspergillosis; Aspergillus niger; Chronic Disease; Drug Therapy, Combination; Female; Hodgkin Disease; Humans; Lung Diseases, Fungal; Lymphatic Irradiation; Necrosis; Pneumonia, Bacterial; Pyrimidines; Radiation Injuries; Radiography; Staphylococcal Infections; Staphylococcus epidermidis; Triazoles; Virginiamycin; Voriconazole | 2006 |
Chronic invasive sinus aspergillosis in an immunocompetent patient: a case report.
Topics: Adult; Antifungal Agents; Aspergillosis; Aspergillus fumigatus; Chronic Disease; Endoscopy; Humans; Immunocompetence; Male; Paranasal Sinus Diseases; Pyrimidines; Tomography, X-Ray Computed; Triazoles; Voriconazole | 2007 |
Aromatase inhibitors in the treatment of severe endometriosis.
Topics: Androstadienes; Aromatase Inhibitors; Chronic Disease; Endometriosis; Estrogen Replacement Therapy; Female; Hot Flashes; Humans; Hysterectomy; Letrozole; Middle Aged; Nitriles; Pelvic Pain; Postmenopause; Treatment Outcome; Triazoles | 2007 |
[Case of pulmonary aspergillosis associated with inappropriate antidiuretic hormone syndrome caused by voriconazole therapy].
Topics: Aged; Antifungal Agents; Aspergillosis; Chronic Disease; Cytochrome P-450 Enzyme System; Humans; Lung Diseases, Fungal; Male; Pituitary ACTH Hypersecretion; Polymorphism, Genetic; Pyrimidines; Triazoles; Voriconazole | 2007 |
Successful treatment of refractory chronic necrotizing pulmonary aspergillosis with micafungin.
Topics: Antifungal Agents; Aspergillosis; Aspergillus fumigatus; Chronic Disease; Drug Resistance, Multiple, Fungal; Echinocandins; Humans; Lipopeptides; Lipoproteins; Lung Diseases, Fungal; Male; Micafungin; Middle Aged; Necrosis; Pyrimidines; Radiography; Triazoles; Voriconazole | 2007 |
Reversal of pathological pain through specific spinal GABAA receptor subtypes.
Topics: Analgesics; Animals; Brain; Capsaicin; Chronic Disease; Diazepam; Disease Models, Animal; Fluorobenzenes; Formaldehyde; Ganglia, Spinal; Hot Temperature; Inflammation; Male; Mice; Neurons; Organ Specificity; Pain; Protein Isoforms; Protein Subunits; Rats; Rats, Wistar; Receptors, GABA-A; Spinal Cord; Triazoles | 2008 |
[Clinical case of the month. Pulmonary aspergillosis: chimic necrotizing aspergillosis].
Topics: Anti-Inflammatory Agents; Antifungal Agents; Aspergillosis; Chronic Disease; Glucocorticoids; Humans; Lung Diseases, Fungal; Male; Methylprednisolone; Middle Aged; Necrosis; Pneumonia; Pulmonary Disease, Chronic Obstructive; Pyrimidines; Sputum; Triazoles; Voriconazole | 2007 |
Effect of anti-IL-4, interferon-gamma and an antifungal triazole (SCH 42427) in paracoccidioidomycosis: correlation of IgE levels with outcome.
Topics: Animals; Antibodies, Monoclonal; Antifungal Agents; Chronic Disease; Immunoglobulin E; Interferon-gamma; Interleukin-4; Mice; Mice, Inbred BALB C; Paracoccidioidomycosis; T-Lymphocytes, Helper-Inducer; Triazoles | 1993 |
Treatment of posttraumatic stress disorder with nefazodone.
Topics: Adolescent; Adult; Aged; Antidepressive Agents, Second-Generation; Arousal; Chronic Disease; Dose-Response Relationship, Drug; Drug Administration Schedule; Female; Humans; Male; Middle Aged; Personality Inventory; Piperazines; Stress Disorders, Post-Traumatic; Treatment Outcome; Triazoles | 1998 |
Nefazodone attenuates the stress-induced facilitation of wet dog shaking behaviour but not the facilitation of sexual behaviour in female rats.
Topics: Animals; Antidepressive Agents, Second-Generation; Chronic Disease; Corticosterone; Estradiol; Female; Male; Piperazines; Posture; Progesterone; Rats; Rats, Long-Evans; Receptor, Serotonin, 5-HT2A; Receptors, Serotonin; Reflex; Sexual Behavior, Animal; Stress, Psychological; Triazoles | 1999 |
Activities of the triazole derivative SCH 56592 (posaconazole) against drug-resistant strains of the protozoan parasite Trypanosoma (Schizotrypanum) cruzi in immunocompetent and immunosuppressed murine hosts.
Topics: Acute Disease; Animals; Chagas Disease; Chronic Disease; Drug Resistance; Female; Immunocompetence; Immunosuppression Therapy; Mice; Nitroimidazoles; Triazoles; Trypanocidal Agents; Trypanosoma cruzi | 2000 |
Nafazodone-induced palinopsia.
Topics: Afterimage; Antidepressive Agents, Second-Generation; Chronic Disease; Depressive Disorder; Humans; Male; Middle Aged; Piperazines; Triazoles | 2000 |
Treatment of chronic depression.
Topics: Antidepressive Agents, Second-Generation; Behavior Therapy; Chronic Disease; Cognitive Behavioral Therapy; Combined Modality Therapy; Depressive Disorder; Humans; Piperazines; Triazoles | 2000 |
Nefazodone, psychotherapy, and their combination for chronic depression.
Topics: Antidepressive Agents, Second-Generation; Chronic Disease; Combined Modality Therapy; Controlled Clinical Trials as Topic; Depressive Disorder; Humans; Piperazines; Placebos; Psychotherapy; Research Design; Triazoles | 2000 |
Nefazodone, psychotherapy, and their combination for chronic depression.
Topics: Antidepressive Agents, Second-Generation; Chronic Disease; Combined Modality Therapy; Controlled Clinical Trials as Topic; Depressive Disorder; Humans; Piperazines; Psychotherapy; Research Design; Triazoles | 2000 |
Nefazodone, psychotherapy, and their combination for chronic depression.
Topics: Antidepressive Agents, Second-Generation; Chronic Disease; Combined Modality Therapy; Depressive Disorder; Humans; Outcome Assessment, Health Care; Piperazines; Placebos; Psychotherapy; Triazoles | 2000 |
Nefazodone, psychotherapy, and their combination for chronic depression.
Topics: Antidepressive Agents, Second-Generation; Chronic Disease; Combined Modality Therapy; Depressive Disorder; Humans; Piperazines; Psychotherapy; Severity of Illness Index; Triazoles | 2000 |
[Antifungal susceptibility testing in chronically recurrent vaginal candidosis as basis for effective therapy].
Topics: Amphotericin B; Antifungal Agents; Candida; Candidiasis; Chronic Disease; Ciclopirox; Female; Fluconazole; Flucytosine; Humans; Itraconazole; Microbial Sensitivity Tests; Naphthalenes; Pyridones; Pyrimidines; Terbinafine; Triazoles; Vaginitis; Voriconazole | 2000 |
Long-term treatment of recurrent and chronic depression.
Topics: Antidepressive Agents; Chronic Disease; Clinical Trials as Topic; Cognitive Behavioral Therapy; Combined Modality Therapy; Cost of Illness; Depressive Disorder; Disability Evaluation; Drug Administration Schedule; Fluoxetine; Humans; Piperazines; Placebos; Recurrence; Treatment Outcome; Triazoles | 2001 |
[Toxicological studies on cefatrizine (S-640 P). 3. Chronic toxicity in rats(author's transl)].
Topics: Administration, Oral; Alanine Transaminase; Animals; Aspartate Aminotransferases; Blood Urea Nitrogen; Body Weight; Bronchitis; Cephalosporins; Chronic Disease; Drinking; Drug Evaluation, Preclinical; Eating; Female; Lung; Male; Pneumonia; Rats; Triazoles | 1976 |
Evidence for platelet-activating factor as a late-phase mediator of chronic pancreatitis in the rat.
Topics: Amylases; Animals; Azepines; Chronic Disease; Diterpenes; Ginkgolides; Lactones; Ligation; Male; Pancreas; Pancreatic Ducts; Pancreatitis; Platelet Activating Factor; Rats; Rats, Inbred Strains; Time Factors; Triazoles | 1990 |
PAF-acether-antagonist WEB 2086 for treatment of chronic idiopathic thrombocytopenia.
Topics: Azepines; Chronic Disease; Drug Evaluation; Humans; Platelet Activating Factor; Thrombocytopenia; Triazoles | 1990 |
[Subchronic toxic effect of the grain fungicide PF-70 on the electrolyte barrier of the gastric mucosa in rats].
Topics: Action Potentials; Animals; Chronic Disease; Disease Models, Animal; Edible Grain; Electric Conductivity; Female; Fungicides, Industrial; Gastric Mucosa; Male; Maneb; Rats; Rats, Inbred Strains; Sulfur; Triazoles; Zineb | 1990 |
Treatment of chronic murine chromoblastomycosis with the triazole SCH39304.
Topics: Animals; Antifungal Agents; Chromoblastomycosis; Chronic Disease; Disease Models, Animal; Female; Itraconazole; Ketoconazole; Male; Mice; Mice, Inbred BALB C; Mice, Nude; Microscopy, Electron; Mitosporic Fungi; Skin; Triazoles | 1990 |
Failure of the platelet-activating-factor antagonist WEB 2086 BS for treatment of chronic autoimmune thrombocytopenia.
Topics: Adult; Aged; Autoimmune Diseases; Azepines; Chronic Disease; Drug Evaluation; Female; Humans; Male; Middle Aged; Platelet Activating Factor; Prospective Studies; Thrombocytopenia; Triazoles | 1990 |
[Effects of trazodone in subjects with partial or total ventilatory insufficiency].
Topics: Aminophylline; Antidepressive Agents; Chronic Disease; Humans; Lung Diseases, Obstructive; Piperazines; Pyridones; Respiratory Insufficiency; Tranquilizing Agents; Triazoles | 1973 |